Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aurion Biotech
AddedFeb 15, 2024
UpdatedJun 18, 2026
Aurion Biotech

Aurion Biotech

Late Stage Private

Aurion Biotech: Clinical-stage biotech firm pioneering advanced therapies to cure blindness.

HQ
Seattle, WA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Aurion Biotech is a clinical-stage biotech company focused on developing advanced therapies to cure blindness. Founded with the mission to restore vision and improve the quality of life for individuals suffering from ocular diseases, Aurion Biotech leverages cutting-edge technology and innovative research. The company's core product pipeline includes transformative treatments aimed at regenerating damaged eye tissues, particularly targeting conditions that lead to blindness. Their market focus is on providing groundbreaking solutions in the field of ophthalmology.

Notable affiliated individuals and investors include leading experts in biotechnology and ophthalmology, as well as prominent venture capital firms specializing in life sciences. Aurion Biotech has achieved significant milestones, including successful preclinical trials and securing substantial funding to advance their research. The company's impact is profound, offering hope to millions affected by vision impairment and positioning itself as a pioneer in the biotech industry dedicated to curing blindness.

Aurion Biotech - Similar Companies

Imagen Biotech logo

Imagen Biotech

Qlaris Bio logo

Qlaris Bio

qlaris.bio

Aureka Biotechnologies logo

Aureka Biotechnologies

aurekabio.com

Curie.Bio logo

Curie.Bio

curie.bio

Visiox logo

Visiox

visioxpharma.com

Auron Therapeutics logo

Auron Therapeutics

aurontx.com

Orchid BioVentures logo

Orchid BioVentures

Revive Biotechnology logo

Revive Biotechnology

revivebiotech.com

Orion BioScience logo

Orion BioScience

Aurita logo

Aurita

auritabio.com

Bionure logo

Bionure

bionure.com

Skylark Bio logo

Skylark Bio

skylarkbio.com

Attralus logo

Attralus

attralus.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Oculogenex logo

Oculogenex

oculogenex.com

Aurion Biotech - Quick Facts

Who are Aurion Biotech's competitors?

Companies similar to Aurion Biotech include Imagen Biotech, Qlaris Bio, Aureka Biotechnologies and Curie.Bio.

When was Aurion Biotech founded?

Aurion Biotech was founded in 2021.

Where is Aurion Biotech's headquarters located?

Aurion Biotech's headquarters is located in Seattle, WA, US.

When was Aurion Biotech's last funding round?

Aurion Biotech's most recent funding round was for $120M (USD) in April 2022.

How much has Aurion Biotech raised to-date?

As of Apr 12, 2022, Aurion Biotech has raised a total of $120M (USD).

How many employees does Aurion Biotech have?

Aurion Biotech has 55 employees as of Feb 5, 2024.

Aurion Biotech - Classification

Ownership
  • Equity
  • Venture Capital
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biotech
  • Therapies
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified